FDA Orders Bard, Others To Study Surgical Mesh Implants
The U.S. Food and Drug Administration has ordered Boston Scientific Corp., C.R. Bard Inc. and 31 other companies to conduct post-market studies of surgical mesh used in vaginal surgeries amid concerns...To view the full article, register now.
Already a subscriber? Click here to view full article